SAA
Southeast Asset Advisors’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.88M | Buy |
15,529
+207
| +1% | +$38.4K | 0.34% | 49 |
|
|
2025
Q1 | $3.21M | Buy |
15,322
+2,339
| +18% | +$490K | 0.39% | 40 |
|
|
2024
Q4 | $2.31M | Sell |
12,983
-414
| -3% | -$73.6K | 0.28% | 55 |
|
|
2024
Q3 | $2.65M | Buy |
13,397
+1
| +0% | +$197 | 0.29% | 53 |
|
|
2024
Q2 | $2.3M | Buy |
13,396
+2
| +0% | +$343 | 0.28% | 55 |
|
|
2024
Q1 | $2.44M | Sell |
13,394
-399
| -3% | -$72.7K | 0.29% | 52 |
|
|
2023
Q4 | $2.14M | Buy |
13,793
+261
| +2% | +$40.4K | 0.28% | 52 |
|
|
2023
Q3 | $2.02M | Buy |
13,532
+1,302
| +11% | +$194K | 0.28% | 46 |
|
|
2023
Q2 | $1.65M | Buy |
12,230
+1
| +0% | +$135 | 0.23% | 60 |
|
|
2023
Q1 | $1.95M | Buy |
12,229
+2,630
| +27% | +$419K | 0.29% | 49 |
|
|
2022
Q4 | $1.55M | Sell |
9,599
-1,383
| -13% | -$223K | 0.25% | 55 |
|
|
2022
Q3 | $1.47M | Sell |
10,982
-1,659
| -13% | -$223K | 0.25% | 54 |
|
|
2022
Q2 | $1.94M | Sell |
12,641
-138
| -1% | -$21.1K | 0.31% | 45 |
|
|
2022
Q1 | $2.07M | Buy |
12,779
+502
| +4% | +$81.4K | 0.28% | 49 |
|
|
2021
Q4 | $1.66M | Buy |
12,277
+28
| +0.2% | +$3.79K | 0.23% | 61 |
|
|
2021
Q3 | $1.32M | Buy |
12,249
+1,882
| +18% | +$203K | 0.22% | 70 |
|
|
2021
Q2 | $1.17M | Buy |
10,367
+7,804
| +304% | +$879K | 0.19% | 71 |
|
|
2021
Q1 | $277K | Buy |
2,563
+444
| +21% | +$48K | 0.05% | 115 |
|
|
2020
Q4 | $227K | Buy |
+2,119
| New | +$227K | 0.05% | 123 |
|